About Fresenius Kabi
Fresenius Kabi is a company founded in 1999. Fresenius Kabi has completed 4 acquisitions, including Akorn, Fenwalinc and Ivenix. Fresenius Kabi offers products and services including IV Drugs and Infusion Therapy and Medical Nutrition.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Fresenius Kabi Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Akorn
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fresenius Kabi
Fresenius Kabi offers a comprehensive portfolio of products and services, including IV Drugs and Infusion Therapy and Medical Nutrition.
IV therapy products are supplied by Fresenius Kabi for anesthetics, oncology, anti-infectives, and critical care to enhance patient outcomes.
Specialized nutrition solutions are offered by Fresenius Kabi, including parenteral and enteral nutrition for various patient needs.
People of Fresenius Kabi
Unlock access to complete
Software Development Team
110 people
Sales and Marketing
53 people
Leadership Team
48 people
Finance and Accounting
29 people
Senior Team
20 people
Product Management Team
12 people
Human Resources and Administration
12 people
Operations Team
7 people
Unlock access to complete
Funding Insights of Fresenius Kabi
Detailed funding history for Fresenius Kabi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fresenius Kabi
Fresenius Kabi has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Akorn, Fenwalinc and Ivenix.
Investment portfolio details for Fresenius Kabi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antibodies, cytokines, and hormones are developed, manufactured, and commercialized.
|
Locked | Locked | 2009 | Locked | |
|
Infusion management systems are developed with wireless web-based architecture.
|
Locked | Locked | 2001 | Locked | |
|
Portfolio of products for transfusion medicine and cell therapy.
|
Locked | Locked | 1949 | Locked |
Complete acquisition details for Fresenius Kabi
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Fresenius Kabi
Detailed financials for Fresenius Kabi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fresenius Kabi Comparisons
Peer comparison for Fresenius Kabi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fresenius Kabi
Detailed competitors of Fresenius Kabi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fresenius Kabi
Complete news archive for Fresenius Kabi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fresenius Kabi
Fresenius Kabi was founded in 1999.
Fresenius Kabi is recognized as a global provider of healthcare products and services, with a focus on lifesaving medicines and technologies for critically ill patients. Its portfolio includes IV drugs, medical nutrition, and biopharmaceuticals that are utilized to support patient care worldwide. Sustainability efforts are emphasized, including reductions in emissions and community support, while maintaining high-quality standards. The companys global presence and commitment to ethical practices are noted in its operations from Bad Homburg, Germany, touching the lives of millions annually through innovative healthcare solutions.
Fresenius Kabi offers IV Drugs and Infusion Therapy and Medical Nutrition.